A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

by | Jan 26, 2026 | Clinical Trials | 0 comments

​ Conditions: Advanced Lung Cancer

Interventions: Drug: TQB6411 for Injection

Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting Conditions: Advanced Lung Cancer
Interventions: Drug: TQB6411 for Injection
Sponsors: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *